These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 2230132)

  • 41. A possible autocrine role for interleukin-6 in two lymphoma cell lines.
    Yee C; Biondi A; Wang XH; Iscove NN; de Sousa J; Aarden LA; Wong GG; Clark SC; Messner HA; Minden MD
    Blood; 1989 Aug; 74(2):798-804. PubMed ID: 2787680
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Leukemia-derived growth factor (non-interleukin-2) produced by murine lymphoma T-cell lines.
    Hays EF; Goodrum D; Bessho M; Kitada S; Uittenbogaart CH
    Proc Natl Acad Sci U S A; 1984 Dec; 81(24):7807-11. PubMed ID: 6595661
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Insulin dependence of murine T-cell lymphoma. II. Insulin-deficient diabetic mice and mice fed low-energy diet develop resistance to lymphoma growth.
    Sharon R; Pillemer G; Ish-Shalom D; Kalman R; Ziv E; Berry EM; Naor D
    Int J Cancer; 1993 Mar; 53(5):843-9. PubMed ID: 8449610
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Production and characterization of immature murine T-lymphoma cell lines.
    Richie ER; Walker DA
    Methods Mol Biol; 2000; 134():177-84. PubMed ID: 10730257
    [No Abstract]   [Full Text] [Related]  

  • 45. Lessons Learned from Targeting IGF-I Receptor in Thyroid-Associated Ophthalmopathy.
    Janssen JAMJL; Smith TJ
    Cells; 2021 Feb; 10(2):. PubMed ID: 33673340
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Insulin-like Growth Factor-I Receptor and Thyroid-Associated Ophthalmopathy.
    Smith TJ; Janssen JAMJL
    Endocr Rev; 2019 Feb; 40(1):236-267. PubMed ID: 30215690
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Co-expression of mFat-1 and pig IGF-1 genes by recombinant plasmids in modified chitosan nanoparticles and its synergistic effect on mouse immunity.
    Xiong Q; Chen J; Li FL; Zhao S; Wan X; Yang X; Li J; Luo D; Wang Z; Lv X; Gao R
    Sci Rep; 2017 Dec; 7(1):17136. PubMed ID: 29215025
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Insulin-like growth factor-1 and childhood cancer risk.
    Badr M; Hassan T; Tarhony SE; Metwally W
    Oncol Lett; 2010 Nov; 1(6):1055-1059. PubMed ID: 22870112
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Infection, immunity and the neuroendocrine response.
    Borghetti P; Saleri R; Mocchegiani E; Corradi A; Martelli P
    Vet Immunol Immunopathol; 2009 Aug; 130(3-4):141-62. PubMed ID: 19261335
    [TBL] [Abstract][Full Text] [Related]  

  • 50. P53 mutation in acute T cell lymphoblastic leukemia is of somatic origin and is stable during establishment of T cell acute lymphoblastic leukemia cell lines.
    Yeargin J; Cheng J; Yu AL; Gjerset R; Bogart M; Haas M
    J Clin Invest; 1993 May; 91(5):2111-7. PubMed ID: 8486778
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Growth hormone and insulin-like growth factor I induce immunoglobulin (Ig)E and IgG4 production by human B cells.
    Kimata H; Fujimoto M
    J Exp Med; 1994 Aug; 180(2):727-32. PubMed ID: 8046348
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human growth hormone promotes engraftment of murine or human T cells in severe combined immunodeficient mice.
    Murphy WJ; Durum SK; Longo DL
    Proc Natl Acad Sci U S A; 1992 May; 89(10):4481-5. PubMed ID: 1584780
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The thymic education of developing T cells in self neuroendocrine principles.
    Geenen V; Robert F; Martens H; De Groote D; Franchimont P
    J Endocrinol Invest; 1992 Sep; 15(8):621-9. PubMed ID: 1430844
    [No Abstract]   [Full Text] [Related]  

  • 54. The nonobese diabetic scid mouse: model for spontaneous thymomagenesis associated with immunodeficiency.
    Prochazka M; Gaskins HR; Shultz LD; Leiter EH
    Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3290-4. PubMed ID: 1373493
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Exogenous IL-7 promotes the growth of CD3-CD4-CD8-CD44+CD25+/- precursor cells and blocks the differentiation pathway of TCR-alpha beta cells in fetal thymus organ culture.
    Plum J; De Smedt M; Leclercq G
    J Immunol; 1993 Apr; 150(7):2706-16. PubMed ID: 8095954
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization and growth factor requirements of SJL lymphomas. I. Development of a B cell growth factor-dependent in vitro cell line, cRCS-X.
    Lasky JL; Ponzio NM; Thorbecke GJ
    J Immunol; 1988 Jan; 140(2):679-87. PubMed ID: 3275720
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interleukin-9 stimulates in vitro growth of mouse thymic lymphomas.
    Vink A; Renauld JC; Warnier G; Van Snick J
    Eur J Immunol; 1993 May; 23(5):1134-8. PubMed ID: 8477807
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The relative roles of interleukins 1, 2, and 3 in the regulation of T cell differentiation.
    Ihle JN; Keller J
    Kroc Found Ser; 1984; 18():399-421. PubMed ID: 6442348
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Insulin-like growth factor-I supports proliferation of autocrine thymic lymphoma cells with a pre-T cell phenotype.
    Gjerset RA; Yeargin J; Volkman SK; Vila V; Arya J; Haas M
    J Immunol; 1990 Nov; 145(10):3497-501. PubMed ID: 2230132
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.